Season 1 Episode 200
Friday’s jobs report and tumbling inflation expectations helped push the S&P 500 to a 2023 high, with the Nasdaq almost there, suggesting the market rally may be on the cusp of another leg higher. Arm Holdings blasted out of an IPO base as chip stocks heat up. Microsoft has held a buy point and a key level. Crispr Therapeutics won a historic FDA approval, but CRSP suffered a classic “sell the news” reversal.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Published on 2 years ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate